Parathyroid adenoma associated with thymoma in a female adult with primary hyperparathyroidism  by Maria, Verroiotou et al.
P
h
V
S
a
A
R
R
A
A
K
T
P
A
H
H
1
i
I
t
a
p
L
a
w
s
o
a
b
y
s
p
T
2
hCASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 4 (2013) 105– 107
Contents lists available at SciVerse ScienceDirect
International  Journal  of  Surgery  Case  Reports
j ourna l ho me page: www.elsev ier .com/ locate / i j scr
arathyroid  adenoma  associated  with  thymoma  in  a  female  adult  with  primary
yperparathyroidism
erroiotou  Maria ∗, Al  Mogrampi  Saad, Fardellas  Ioannis
urgical Clinique, Naousa General Hospital, Afoi Lanara & Pexlivanou 3, 59200 Naousa, Imathia, Greece
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 28 March 2012
eceived  in revised form 28 August 2012
ccepted 3 September 2012
vailable online 23 October 2012
eywords:
hymoma
arathyroid
denoma
yperparathyroidism
ypercalcemia
a  b  s  t  r  a  c  t
INTRODUCTION:  Parathyroid  adenoma  associated  with  a thymoma  is  a rare  clinical  entity  and  few  cases
have  been  reported  in  the literature.  This association  can  be  explained  by  the  common  embryologic
origin  of  the  parathyroid  glands  and  the  thymus.  These  patients  may  present  only  with  clinical  signs and
symptoms  of  primary  hyperparathyroidism  making  it difﬁcult  to  suspect  the  coexistence  of thymoma.
PRESENTATION OF  CASE:  A  68-year-old  female  with  medical  history  of  primary  hyperparathyroidism
underwent  surgical  excision  of  a single  parathyroid  adenoma.  Intra-operatively  a small  mass  was  detected
in  the  proximity  of  the  parathyroid  adenoma  and  was  also  removed.  Pathologic  examination  revealed
parathyroid  adenoma  as suspected  pre-operatively  whereas  the  small  mass  excised  was  identiﬁed  as a
type  A  thymoma.  The  postoperative  course  of  the patient  was  favourable,  with  normal  serum  calcium
levels  and  in six months  follow-up  the  patient  is  symptom-free  and  with  no  recurrence.
DISCUSSION: Objective  of  this  study  is  to  report  the  rare case  of a  female  adult  with  a parathyroid  adenoma
and  a coexisting  thymoma  in order  to underline  the  importance  of these  two  pathologies  and  the  ideal
treatment  that  should  be followed  according  to the  latest  records.
CONCLUSION: Surgical  removal  of parathyroid  adenoma  is  the  treatment  of  choice  for  primary  hyper-
parathyroidism,  with  complete  recovery  and  no postoperative  complications.  Thymoma  may  be
associated  with  primary  hyperparathyoridism,  with  or  without  clinical  signs  and symptoms  of myas-
thenia  gravis  and  this  is a rare clinical  entity  as  very  few  cases  have  been  described  worldwide.  To  our
knowledge  this  is the  ﬁrst  case  reported  in  Greece.
gical © 2012 Sur
. Introduction
Parathyroid adenoma associated with a thymoma is a rare clin-
cal entity and very few cases have been reported in the literature.
n order to explain this possible association it is essential to refer
hat embryologically, the inferior parathyroid glands and thymus
re derived from the third pharyngeal pouch, while the superior
arathyroid glands originate from the fourth pharyngeal pouch.
ater on, the inferior parathyroid glands separate from the thymus
nd come to lie posterior to the thyroid glands.1
Patients diagnosed with parathyroid adenoma usually present
ith clinical signs and symptoms of primary hyperparathyroidism
ince parathyroid neoplasms are responsible for approximately 85%
f all cases of primary hyperparathyroidism and the vast majority
re benign (95%).2 On the other hand, thymoma may  not always
e clinically evident. It is exceedingly uncommon in children and
oung adults, rises in incidence in middle age, and peaks in the
eventh decade of life while its’ overall incidence in the US is 0.13
er 100,000 person-years.3
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Given this uncommon clinical entity, a review of the literature
followed in the international electronic database (Pubmed).
Byrne  et al. describe the case of a 65-year-old female patient
with a history of myasthenia gravis, not medically controlled, who
underwent thymectomy and simultaneous excision of three and a
half parathyroid glands. Pathologic examination posed the diag-
nosis of lymphocytic thymoma and nodular hyperplasia of the
parathyroid glands. Post-operatively the patient was eucalcemic
and the symptoms from myasthenia gravis were reduced.4
Palmer et al. report two cases of hyperparathyroidism in which
one patient had an associated chemodectoma and the other had a
thymoma and myasthenia gravis.5
Palin et al. describe the case of a 67-year-old female patient with
hyperparathyroidism, who  underwent surgical removal of parathy-
roid adenoma.
Post-operatively the patient presented symptoms that raised
the suspicion of myasthenia gravis, later diagnosed by the detection
of high levels of acetylcholine receptor antibodies. Further investi-
gation with a normal chest radiograph and thoracic CT scan failed
to show the presence of a thymoma, although antibodies to stri-
Open access under CC BY-NC-ND license.ated muscle were detected. The patient was  medically controlled
and was symptom-free, yet as a conclusion there was  no certainty
that myasthenia gravis was associated with hyperparathyroidism,
since there was  a possibility that the syndrome could have been
 BY-NC-ND license.
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aFig. 1. Left inferior parathyroid gland.
recipitated by administration of pamidronate, as a treatment for
ypercalcemia.6
According to Suzuki et al. a 50-year-old female with
yperparathyroidism and parathyroid adenoma presented a non-
nvasive thymoma and was treated with concomitant extended
hymectomy and resection of the right superior parathyroid gland.
he patient did not evidence myasthenia gravis and in a two years
ollow-up she had no recurrence.7
Triggiani et al. describe a patient with myasthenia gravis due to a
ide invasive malignant thymoma associated with hyperparathy-
oidism caused by parathyroid adenoma.8
Most recent report of coexisting thymoma and parathyroid ade-
oma is described by Ceriani et al. and was discovered by sestamibi
arathyroid scintigraphy.9
Objective of this study is to present the case of a female adult
ho was surgically treated for primary hyperparathyroidism due
o a parathyroid adenoma and who was also diagnosed post-
peratively with thymoma, until then asymptomatic. According to
ur research this is the ﬁrst case reported in Greece.
. Presentation of case
A 68-year-old female was diagnosed with primary hyper-
arathyroidism and underwent surgical excision of a single
arathyroid adenoma. According to the patient’s history she was
nder treatment for diabetes and hypertension, while she was
rescribed to take Cinacalcet 30 mg  daily until the operation day,
n order to normalise the high serum calcium levels. During the
re-operative control, thyroid ultrasonography demonstrated an
nlarged hypo-echoic left inferior parathyroid gland suggestive for
 parathyroid adenoma. The left superior parathyroid gland and
he right superior and inferior parathyroid glands were found to
e eutopic and of normal size. Pre-operatively serum calcium was
0.2 mg/dL (normal: 8.5–10.4 mg/dL) and parathyroid hormone
PTH) level of 124.2 pg/ml (normal: 10–65 pg/ml).
Neck exploration was performed through a transverse cervical
ncision. In the inferior pole of the left thyroid lobe an enlarged
arathyroid gland was found (Fig. 1) and excised and an intra-
perative parathyroid hormone level was determined by a blood
ample taken from a peripheral vein catheter, ﬁfteen minutes
fter the removal of the parathyroid adenoma, that demonstrated
 reduction of the PTH level of 58%. In the proximity of theFig. 2. Parathyroid adenoma up on the left and thymoma down on the right.
excised parathyroid gland a small oval mass was  identiﬁed and also
removed (Fig. 2). The right superior and inferior parathyroid glands
and the left superior parathyroid gland were identiﬁed and found
normal.
Pathologic examination of the ﬁrst specimen revealed a parathy-
roid adenoma, size 3 cm × 1.5 cm × 1 cm while the second specimen
of size 1.3 cm × 1 cm × 0.6 cm was identiﬁed as type A thymoma
(Fig. 3).
The  patient had an uneventful postoperative course and was
discharged in the 3d postoperative day. In a six months follow-up
the patient is eucalcemic and with no symptoms of any kind.
3.  Discussion
There are few cases documented worldwide of parathyroid ade-
noma associated with thymoma. To our knowledge this is the ﬁrst
case reported in Greece.
Objective  of this study is to present a case of concomitant pres-
ence of these two  important neoplasms in a 68-year-old female
patient who was  surgically treated for primary hyperparathy-
roidism due to parathyroid adenoma and was  also diagnosed
post-operatively with thymoma identiﬁed intra-operatively as a
small mass in the proximity of the excised parathyroid adenoma.
In  the case of parathyroid adenoma, the only deﬁnitive
treatment for primary hyperparathyroidism is curative parathy-
roidectomy, which is deﬁned by normocalcemia after surgery.13
The patient was also diagnosed with a type A thymoma. Type
A thymoma (also known as spindle cell thymoma and medullary
thymoma) accounts for approximately 4–7% of all thymomas.10,11Approximately 17% of this type may  be associated with myasthenia
gravis.10 Morphologically the tumour is composed of neoplas-
tic thymic epithelial cells that have spindle/oval shape, lack
nuclear atypia, and are accompanied by few, if any non neoplastic
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1ig. 3. Surgical specimens of parathyroid adenoma on the right and thymoma on
he left.
ymphocytes.12 The prognosis of this tumour type is excellent and
as long-term survival rates (15 years or more) that are reported
o be close to 100% in retrospective studies.10,11
In our case the patient in a six months follow-up is symptom-
ree.
When thymoma is associated with myasthenia gravis surgi-
al removal is the treatment of choice, in case of encapsulated
hymomas, whereas in case of invasive thymomas postoperative
adiotherapy is advisable regardless of the extent of the resection.14
In our study the patient had no medical record for myasthe-
ia gravis, no clinical signs or symptoms that could be indicative
f the disease and thymectomy was considered to be the curative
reatment.
A recent study of Welch et al. proposes transcervical thymec-
omy, even in absence of thymic lesions because according to the
onclusions there is a high yield of parathyroid tissue within the
hymus gland and this results essential for the cure of selected
atients with hyperparathyroidism.15
In this case report a 68-year-old female patient treated for
rimary hyperparathyroidism with parathyroidectomy, due to
arathyroid adenoma was also diagnosed with thymoma.
Thymus gland and parathyroid glands have common embry-
logic origin and therefore, during the surgical procedure
f parathyroidectomy for parathyroid adenoma, it is essen-
ial a cautious and scrupulous exploration of the surgical
eld in order to identify the adenoma that may  be located
n the proximity of the thymus gland, which should be
emoved in these cases, since it may  veil malignant alter-
tions.. Conclusion
Due to the intimate developmental relationship of parathyroid
land and thymus gland it is essential to seek for the possible
1PEN  ACCESS
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presence  of thymic lesions when treating patients with primary
hyperparatyroidism, especially in those cases whose patient his-
tory is negative for myasthenia gravis and the suspision of a possible
coexisting thymoma may  not be evident.
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